在晚期生殖尿路癌症中,个性化治疗策略的实施和结果
A Klostermann1, T Debertshäuser2, M Benary2
1Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
ESMO open
|July 2, 2025
概括
分子瘤委员会为许多晚期泌尿生殖系统 (GU) 癌症患者确定了个性化治疗方法,在很大一部分患者中显示出临床益处,特别是那些患有罕见瘤类型的患者.
科学领域:
- 在瘤学瘤学.
- 生殖尿道癌症 生殖尿道癌症
- 个性化医疗是个性化的医疗.
背景情况:
- 晚期生殖泌尿系统 (GU) 癌症对标准治疗耐药,预后不佳.
- 分子瘤板 (MTB) 越来越多地用于个性化治疗策略.
- 关于MTBs在GU恶性瘤中的疗效的数据有限.
研究的目的:
- 评估分子瘤委员会讨论对GU癌症患者治疗策略和治疗结果的影响.
- 评估分子匹配疗法 (MMT) 的识别及其临床益处.
- 分析罕见的GU瘤类型患者的结局.
主要方法:
- 在2016-2023年期间的MTB中讨论的126名GU癌症患者的回顾性分析.
- 分子分析包括免疫组织化学,面板测序和全外/转录组测序.
- 临床益处定义为CR,PR或SD>6个月,或PFS比率>1.3对于MMT与非MMT.
主要成果:
- 在68%的患者 (78/115),确定了MMT选项.
- 22%的患者 (25/115) 接受了MMT,其中28.6% (8/28) 显示临床益处.
- 患有罕见GU实体的患者的MMT选择率 (78%) 和MMT治疗率 (35%) 较高.
结论:
- 分子瘤委员会可以为大多数GU癌症患者确定MMT选择,包括那些严重预治疗的患者.
- 在接受MMT的患者中观察到临床反应.
- 建议对GU癌症进行进一步的受控试验和分子分析的整合,特别是罕见的组织学.
更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.7K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Kidney Transplant III: Nursing Management
85
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
85
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
